Espinel-Bermúdez MC, Sánchez-García S, García-Peña C, Trujillo X, Huerta-Viera M, Granados-García V, Hernández-González S, Arias-Merino ED

Language: Spanish
References: 25
Page: 46-53
PDF size: 292.69 Kb.

ABSTRACT

Background: Sarcopenia involves the loss of skeletal muscle mass and age-related functionality; it diminishes physical independence, health and quality of life. In 2016 it was added to the International Classification of Diseases (ICD-10). Information about the frequency of sarcopenia among Mexican older adults is scarce. The objective was to analyze associated factors with sarcopenia in Mexican older adults through the 2012 National Health and Nutrition Survey data.
Methods: Cross-sectional study which included subjects of 60 years of age or more with simultaneous information on health and anthropometry questionnaires from the 2012 National Health and Nutrition Survey. Sarcopenia was diagnosed through a gait speed test and calf circumference. It was assessed the prevalence of sarcopenia and its association with sociodemographic characteristics and variables related to health, tobacco use and alcohol consumption. The analysis was performed with SPSS v. 16.
Results: We analyzed a sample of 5046 older adults who represented 7 439 686 older adults nationwide. Among subjects 53.9% (n = 2718) were women (mean age 69.92 ± 7.56 years) and 46.1% (n = 2328), men (mean age 70.43 ± 7.73 years). Prevalence of presarcopenia was 8.70% and sarcopenia, 13.30%.
Conclusion: Sarcopenia was more prevalent in women and it increases with age. It has a significant relationship with falls, cognitive impairment, central obesity and high levels of marginalization.

REFERENCES

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-23.

2. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008; 12(7):433-50.

3. International Working Group on Sarcopenia. Sarcopenia: An Undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology and consequences. I Am Med Dir Assoc. 2011;12 (4):249-56.

4. Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015;16:247-52.

5. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz- Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optical dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-59.

6. Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014;14 Suppl 1:15-28. doi:10.1111/ggi.12220.

7. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512-4.

8. Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43 (6):748-59.

9. Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height, weight, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31:643-50.

10. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. Journal of Diabetes & Metabolic Disorders. 2017;16:21. doi 10.1186/s40200-017-0302-x

11. Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU. Prevalence of sarcopenia in Mexico City. Eur Geriatric Med. 2012(3):157-60.

12. Espinel-Bermúdez MC, Ramírez-García E, García- Peña C, Salvà A, Ruiz-Arregui L, Cárdenas-Bahena A et al. Prevalence of sarcopenia in communitydwelling older people of Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria. JCSM Clinical Reports. 2017(2) doi:10.17987/jcsm-cr.v2i2.9.

13. Hernández-Ávila M. Editorial. Salud Publica Mex. 1998;40(1):1-2.

14. Gutierrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernandez S, Franco A, Cuevas-Nasu L et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. Segunda edición. Cuernavaca, México: Instituto Nacional de Salud Pública; 2013.

15. Romero-Martínez M, Shamah-Levy T, Franco-Núñez A, Villalpando S, Cuevas-Nasu L, Gutiérrez JP et al. Encuesta Nacional de Salud y Nutrición 2012: diseño y cobertura. Salud Publica Mex. 2013; 55:S332-34.

16. Bahat G, Tufan F, Saka B, Akin S, Ozkaya H, Yucel N, et al. Which body mass index (BMI) is better in the elderly for functional status? Arch Gerontol Geriatr. 2012;54(1):78-81.

17. Barquera S, Campos-Nonato I, Hernández-Barrera L, Pedroza A, Rivera-Dommarco JA. Prevalencia de obesidad en adultos mexicanos, 2000-2012. Salud Publica Mex. 2013;55:S151-60.

18. Domínguez-Orozco ME, Serrano-Otero MM, Jiménez- Perez MC, Perea-Perea F. Aplicación de la Escala CAMCOG en el diagnóstico de demencias: Análisis de casos. Revista electrónica de Psicología Iztacala. 2013;16(2):458-75.

19. Kawakami R, Murakami H, Sanada K, Tanaka N, Sawada SS, Tabata I, et al. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int. 2015;15(8):969-76.

20. Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16:170: doi:10.1186/s12877-016-0349-4.

21. Kim KC, Shin DH, Lee SY, Im JA, Lee DC. Relation between Obesity and Bone Mineral Density and Vertebral Fractures in Korean Postmenopausal Women. Yonsei Med J. 2010;51(6):857-63.

22. Donini LM, Scardella P, Piombo L, Neri B, Asprino R, Proietti AR, et al. Malnutrition in elderly: social and economic determinants. J Nutr Health Aging. 2013;17(1):9-15.

23. Lee J, Hong YP, Shin HJ, Lee W. Associations of Sarcopenia and Sarcopenic Obesity with Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength. J Prev Med Public Health. 2016;49(1):35-44.

24. Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Relation Between Cigarette Smoking and Sarcopenia: Meta-Analysis. Physiol Res. 2015;64:419-26.

25. Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Alcohol consumption as a risk factor for sarcopenia - a meta-analysis. BMC Geriatr. 2016; 11;16:99. doi: 10.1186/s12877-016-0270-x.